Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015048
Filing Date
2024-11-08
Accepted
2024-11-08 16:01:53
Documents
74
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 2150120
2 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 16510
3 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 13475
4 EX-32.1 tmb-20240930xex32d1.htm EX-32.1 7669
5 EX-32.2 tmb-20240930xex32d2.htm EX-32.2 6982
  Complete submission text file 0001558370-24-015048.txt   7497977

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20240930.xsd EX-101.SCH 62148
7 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 48572
8 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 264977
9 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 410043
10 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 368808
77 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 1065203
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38191 | Film No.: 241440386
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)